CN1988892A - 纳米粒子及其制备方法 - Google Patents

纳米粒子及其制备方法 Download PDF

Info

Publication number
CN1988892A
CN1988892A CNA2005800213793A CN200580021379A CN1988892A CN 1988892 A CN1988892 A CN 1988892A CN A2005800213793 A CNA2005800213793 A CN A2005800213793A CN 200580021379 A CN200580021379 A CN 200580021379A CN 1988892 A CN1988892 A CN 1988892A
Authority
CN
China
Prior art keywords
nanoparticles
gelatin
less
weight
molecular weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2005800213793A
Other languages
English (en)
Chinese (zh)
Inventor
M·阿勒斯
C·考斯特
K·茨维奥克
Z·兹雷斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gelita AG
Original Assignee
Gelita AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gelita AG filed Critical Gelita AG
Publication of CN1988892A publication Critical patent/CN1988892A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5169—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Jellies, Jams, And Syrups (AREA)
CNA2005800213793A 2004-08-20 2005-08-18 纳米粒子及其制备方法 Pending CN1988892A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004041340A DE102004041340A1 (de) 2004-08-20 2004-08-20 Nanopartikel und Verfahren zu deren Herstellung
DE102004041340.1 2004-08-20

Publications (1)

Publication Number Publication Date
CN1988892A true CN1988892A (zh) 2007-06-27

Family

ID=35276582

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2005800213793A Pending CN1988892A (zh) 2004-08-20 2005-08-18 纳米粒子及其制备方法

Country Status (14)

Country Link
US (1) US20080003292A1 (enExample)
EP (1) EP1793810A1 (enExample)
JP (1) JP2008510688A (enExample)
KR (1) KR20070046850A (enExample)
CN (1) CN1988892A (enExample)
AU (1) AU2005276675A1 (enExample)
BR (1) BRPI0514524A (enExample)
CA (1) CA2575407A1 (enExample)
DE (1) DE102004041340A1 (enExample)
IL (1) IL180954A0 (enExample)
MX (1) MX2007001996A (enExample)
NO (1) NO20071458L (enExample)
NZ (1) NZ551326A (enExample)
WO (1) WO2006021367A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103298498A (zh) * 2010-11-10 2013-09-11 坦吉恩股份有限公司 用于器官增强的注射制剂
CN103826738A (zh) * 2011-08-04 2014-05-28 嘉利达股份公司 制造纳米粒子稳定分散体的方法、所制造的分散体及其应用
CN103841965A (zh) * 2011-07-01 2014-06-04 未来化学控股有限公司 明胶纳米微粒的连续流生产

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006325225B2 (en) 2005-12-14 2013-07-04 Cytos Biotechnology Ag Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
WO2007072982A1 (en) * 2005-12-20 2007-06-28 Fujifilm Corporation Protein nanoparticles and the use of the same
JP2007224012A (ja) * 2006-01-30 2007-09-06 Fujifilm Corp 酵素架橋したタンパク質ナノ粒子
SI2032592T1 (sl) 2006-06-12 2013-10-30 Cytos Biotechnology Ag Postopki za pakiranje oligonukleotidov v virusu-podobne delce RNA bakteriofagov
JP2008001764A (ja) * 2006-06-21 2008-01-10 Gunma Univ タンパク質からなる粒子状成形体の製造方法及び、該方法により得られたタンパク質からなる粒子状成形体
JP5275561B2 (ja) * 2006-10-30 2013-08-28 富士フイルム株式会社 水分散可能なナノ粒子
DE602007002784D1 (de) * 2007-03-16 2009-11-26 Univ Nat Chi Nan Bioabbaubares Material mit Nanoporen und elektrischer Leitfähigkeit sowie Herstellungsverfahren dafür
JP2008260705A (ja) * 2007-04-11 2008-10-30 Fujifilm Corp 注射用組成物
JP2008297241A (ja) * 2007-05-31 2008-12-11 Fujifilm Corp ニキビ用皮膚外用剤
DE102007041625A1 (de) * 2007-09-03 2009-03-05 Sinn, Hannsjörg, Dr. Neue Gelatine-Wirkstoff-Konjugate
JP6851987B2 (ja) * 2015-12-25 2021-03-31 コニカミノルタ株式会社 ゼラチン粒子、ゼラチン粒子の製造方法、ゼラチン粒子内包細胞、およびゼラチン粒子内包細胞の製造方法
US11207258B2 (en) 2016-01-25 2021-12-28 Suntory Holdings Limited Capsule containing functional substance and method for manufacturing said capsule
CN107376008B (zh) 2017-07-21 2019-10-22 深圳华诺生物科技有限公司 一种无机纳米颗粒-明胶核壳结构复合材料颗粒的制备方法
WO2021132741A1 (ko) * 2019-12-23 2021-07-01 주식회사 피엘마이크로메드 색전 시술 입자 및 이의 제조방법
WO2021146240A1 (en) 2020-01-13 2021-07-22 Cargill, Incorporated Turkey collagen hydrolysates and methods of making
EP3954399B1 (en) * 2020-04-09 2023-11-15 Plmicromed Co., Ltd. Microbeads for embolization and composition for treating proliferative diseases
KR102386631B1 (ko) * 2020-04-09 2022-04-15 주식회사 피엘마이크로메드 색전 시술용 마이크로 비드 및 증식성 질환 치료용 조성물
KR102645182B1 (ko) * 2021-08-23 2024-03-07 전남대학교산학협력단 젤라틴 가교입자의 제조 방법
KR102861315B1 (ko) * 2022-07-26 2025-09-18 전남대학교산학협력단 작물 생장 촉진용 조성물
US20240049705A1 (en) * 2022-07-26 2024-02-15 Industry Foundation Of Chonnam National University Composition for enhancing growth of plants

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107288A (en) * 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
AU671965B2 (en) * 1991-12-05 1996-09-19 Alfatec-Pharma Gmbh Pharmaceutically Applicable Nanosol and Process for Preparing The Same
DE4140185C2 (de) * 1991-12-05 1996-02-01 Alfatec Pharma Gmbh Ein 2-Arylpropionsäurederivat in Nanosolform enthaltendes Arzneimittel und seine Herstellung
DE4140183C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Flurbiprofen enthaltendes Arzneimittel
DE4140195C2 (de) * 1991-12-05 1994-10-27 Alfatec Pharma Gmbh Pharmazeutisch applizierbares Nanosol und Verfahren zu seiner Herstellung
DE19838189A1 (de) * 1998-08-24 2000-03-02 Basf Ag Stabile pulverförmige Vitamin- und Carotinoid-Zubereitungen und Verfahren zu deren Herstellung
DE60024791T2 (de) * 1999-04-08 2006-07-06 The Johns Hopkins University Antigen-spezifische induktion der peripheren immuntoleranz
US7713551B2 (en) * 2002-09-11 2010-05-11 Elan Pharma International Ltd. Gel stabilized nanoparticulate active agent compositions
CA2435632A1 (en) * 2003-07-21 2005-01-21 Warren Hugh Finlay Formulation of powder containing nanoparticles for aerosol delivery to the lung

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103298498A (zh) * 2010-11-10 2013-09-11 坦吉恩股份有限公司 用于器官增强的注射制剂
CN107823706A (zh) * 2010-11-10 2018-03-23 因瑞金公司 用于器官增强的注射制剂
CN107823706B (zh) * 2010-11-10 2022-02-01 因瑞金公司 用于器官增强的注射制剂
CN103841965A (zh) * 2011-07-01 2014-06-04 未来化学控股有限公司 明胶纳米微粒的连续流生产
US9289499B2 (en) 2011-07-01 2016-03-22 Futurechemistry Holding B.V. Continuous flow production of gelatin nanoparticles
CN103841965B (zh) * 2011-07-01 2016-08-17 未来化学控股有限公司 明胶纳米微粒的连续流生产
CN103826738A (zh) * 2011-08-04 2014-05-28 嘉利达股份公司 制造纳米粒子稳定分散体的方法、所制造的分散体及其应用

Also Published As

Publication number Publication date
KR20070046850A (ko) 2007-05-03
EP1793810A1 (de) 2007-06-13
BRPI0514524A (pt) 2008-06-10
IL180954A0 (en) 2007-07-04
NO20071458L (no) 2007-03-19
US20080003292A1 (en) 2008-01-03
NZ551326A (en) 2010-04-30
CA2575407A1 (en) 2006-03-02
AU2005276675A1 (en) 2006-03-02
DE102004041340A1 (de) 2006-02-23
WO2006021367A1 (de) 2006-03-02
MX2007001996A (es) 2007-05-10
JP2008510688A (ja) 2008-04-10

Similar Documents

Publication Publication Date Title
US20080003292A1 (en) Nanoparticles and method for the production thereof
Lammel et al. Recombinant spider silk particles as drug delivery vehicles
AU649533B2 (en) Method of preparing microspheres
ES2204837T3 (es) Metodo para la preparacion de microesferas que contienen sistemas coloidales.
CN100418619C (zh) 可注射水凝胶微球和形成水凝胶微球的方法
KR20220140700A (ko) 염증-반응성의 항-염증성 하이드로겔
JP2001504828A (ja) 制御型放出システムの調製方法
KR20070083927A (ko) 젤 입자의 형태유지 응집체를 형성하는 방법 및 그 용도
JPH07503700A (ja) カチオン生体ポリマーによるタンパク質の安定化
ES2222507T3 (es) Microesferas de liberacion controlada.
US20060104970A1 (en) Biological glue based on thrombin-conjugated nanoparticles
CN105963256A (zh) 微粒子、血液代用品及其形成方法
Florczak et al. Optimization of spider silk sphere formation processing conditions to obtain carriers with controlled characteristics
Na et al. Thermoresponsive pore structure of biopolymer microspheres for a smart drug carrier
WO2009079688A1 (en) Porous silica shell-mediated assembly of macromolecular capsules
JP4599550B2 (ja) ナノゲル工学によるハイブリッドゲルの調製とバイオマテリアル応用
JP4641721B2 (ja) 生物活性物質を担持するためのもしくは担持した微小粒子を含む組成物、ならびにそれらの調製方法
Vinay et al. Protein and Peptide Nanoparticles: Preparation and Surface Modification
JPWO2018088541A1 (ja) 薬物放出制御用ハイドロゲル及びその製造方法
JP4665131B2 (ja) 高分子電解質複合体およびその製造方法
Lee et al. Biphasic release characteristics of dual drug-loaded alginate beads
Hussein et al. Optimization of gelatin nanofabrication as a potential biocompatible nanocarrier
HK1107762A (en) Nanoparticles and method for the production thereof
Wang et al. Preparation and characterization of a iRGD-modified recombinant spider silk particles for antitumor polypeptide drug delivery into cancer cells
Jana et al. Chitosan-based interpenetrating polymer networks: Drug delivery application

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1107762

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20070627

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1107762

Country of ref document: HK